Sign up for Blog updates

phaeodactylum

New
Algatech|

How FucoVital™ may contribute to improved triglycerides levels and positively affect metabolic syndrome

fucoxanthin was shown in a pre clinical study to inhibit lipase activity in the gastrointestinal tract resulting in decreased triglyceride absorption

New
Algatech|

Algatech Triples FucoVital Production Capacity

Algatech announces it has tripled its production capacity for FucoVital. The action follows increased demand from the dietary supplements market.

New
David Foreman|

Nonalcoholic Fatty Liver and How Fucoxanthin Might Help

FucoVitalTM is the only 3% fucoxanthin extract that targets the first stage of fatty liver by reducing the simple accumulation of fat in the liver. Algatech’s FucoVitalTM is, the first fucoxanthin derived from microalgae and is cultivated year-round in an industrial closed and controlled system, fully exposed to natural sunlight

Algatech|

Study shows FucoVital to be more effective than Silymarin in preventing harmful fat accumulation in liver cells

FucoVital shown to be more effective than Silymarin in preventing harmful fat accumulation in liver cells